RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer
Open Access
- 15 February 2022
- journal article
- retracted article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Abstract
In addition to its role as a TB vaccine, BCG has been shown to elicit heterologous protection against many other pathogens including viruses through a process termed trained immunity. Despite its potential as a broadly protective vaccine, little has been done to determine if BCG-mediated trained immunity levels can be optimized. Here we re-engineer BCG to express high levels of c-di-AMP, a PAMP recognized by stimulator of interferon genes (STING). We find that BCG overexpressing c-di-AMP elicits more potent signatures of trained immunity including higher pro-inflammatory cytokine responses, greater myeloid cell reprogramming toward inflammatory and activated states, and enhances epigenetic and metabolomic changes. In a model of bladder cancer, we also show that re-engineered BCG induces trained immunity and improved functionality. These results indicate that trained immunity levels and antitumor efficacy may be increased by modifying BCG to express higher levels of key PAMP molecules.Keywords
All Related Versions
Funding Information
- Willowcroft Foundation
This publication has 59 references indexed in Scilit:
- mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunityScience, 2014
- Does BCG revaccination protect against the development of asthma?Respiratory Medicine, 2013
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- Recombinant BCG as a vaccine vehicle to protect against tuberculosisBioengineered Bugs, 2010
- Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: Protection against Bordetella pertussis challenge in neonatesVaccine, 2009
- Autophagy and Its Role in MHC-Mediated Antigen PresentationThe Journal of Immunology, 2009
- Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cellsNature Medicine, 2009
- Host Genetics of Mycobacterial Diseases in Mice and Men: Forward Genetic Studies of BCG-osis and TuberculosisAnnual Review of Genomics and Human Genetics, 2007
- Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysinJournal of Clinical Investigation, 2005
- BCG as Adjuvant Immunotherapy for NeoplasiaAnnual Review of Medicine, 1977